Spectramax Light Therapy for Parkinson’s Named ‘Breakthrough Device’ – Parkinson’s News Today

The United States Food and Drug Administration (FDA) has granted breakthrough device designation to PhotoPharmics‘s light-based, at-home device as an add-on therapy for Parkinson’s disease.

This designation is given to medical devices with the potential to offer more effective treatment for life-threatening or debilitating diseases. It grants the company access to experts at the FDA during development, and paves the way for prioritized review of approval requests.

Click here to read full article https://parkinsonsnewstoday.com/2020/05/04/spectramax-light-therapy-photopharmics-designated-breakthrough-devise-fda/

Font Resize